| Particulars |
|
|
|
| Company Name
| Alembic Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
39.31 |
B.V. (₹) |
267.30 |
| Sales(₹ Cr.) |
6,032.63 |
NP (₹ Cr.) |
488.93 |
| NP Var% |
-27.00 |
Div% |
550.00 |
| CPS(₹) |
39.00 |
EPS (₹) |
24.90 |
| Traded Value(₹ Lakhs) |
23.53 |
52 Week High |
1,108.00 |
| 52 Week Low |
726.00 |
Price BSE |
750.00 |
| Price NSE |
751.00 |
Market Capital (₹ Cr.) |
14,745.18 |
| P/C Ratio |
19.20 |
P/E Ratio |
30.20 |
| Price Vs.BV |
2.81 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
1,642.24 |
| NP(₹ Cr.) |
149.30 |
NP Var % |
74.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
6,118.85 |
| OPM |
19.91 |
NP |
766.41 |
| NP Var% |
-18.01 |
EPS |
25.82 |
| PE |
29.05 |
|
|